Applied Genetic Technologies (AGTC) Reports Q3 Loss of $0.40/sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. ABBV
4. LITE
5. CL
6. LYB
7. TFII
8. NVT
9. SPY
10. AAPL

Go back to Applied Genetic Technologies (AGTC) Reports Q3 Loss of $0.40/sh

AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2021

May 17, 2021 4:05 PM EDT

- Reported 50% response rate in visual sensitivity among patients in highest dose groups in ongoing Phase 1/2 clinical trial of its XLRP gene therapy candidate for patients who met inclusion criteria for Skyline and Vista trials -

- Company on track to provide multiple data readouts for its XLRP and ACHM clinical programs in 2021 and 2022 -

- Company plans to lease 21,000 square foot build-to-suit cGMP manufacturing facility adjacent to its Florida facility -

- Company to host conference call and webcast today at 4:30 p.m. ET -

... More